Mass spectrometry‐based analysis on the impact of whole blood donation on the global plasma proteome

Abstract

AbstractBackgroundBiomonitoring may provide important insights into the impact of a whole blood donation for individual blood donors.Study Design and MethodsHere, we used unbiased mass spectrometry (MS)‐based proteomics to assess longitudinal changes in the global plasma proteome, after a single blood donation for new and regular donors. Subsequently, we compared plasma proteomes of 76 male and female whole blood donors, that were grouped based on their ferritin and hemoglobin (Hb) levels.ResultsThe longitudinal analysis showed limited changes in the plasma proteomes of new and regular donors after a whole blood donation during a 180‐day follow‐up period, apart from a significant short‐term decrease in fibronectin. No differences were observed in the plasma proteomes of donors with high versus low Hb and/or ferritin levels. Plasma proteins with the highest variation between and within donors included pregnancy zone protein, which was associated with sex, Alfa 1‐antitrypsin which was associated with the allelic variation, and Immunoglobulin D. Coexpression analysis revealed clustering of proteins that are associated with platelet, red cell, and neutrophil signatures as well as with the complement system and immune responses, including a prominent correlating cluster of immunoglobulin M (IgM), immunoglobulin J chain (JCHAIN), and CD5 antigen‐like (CD5L).DiscussionOverall, our proteomic approach shows that whole blood donation has a limited impact on the plasma proteins measured. Our findings suggest that plasma profiling can be successfully employed to consistently detect proteins and protein complexes that reflect the functionality and integrity of platelets, red blood cells, and immune cells in blood donors and thus highlights its potential use for donor health monitoring.